Other
Hemiplegia
5
Pipeline Programs↗
2
Active Trials↗
4
Companies Involved↗
Hemiplegia is an early-stage landscape with 5 programs across 4 companies. The most active players are Jazz Pharmaceuticals, Vitae Pharmaceuticals Inc., an Allergan affiliate, Ultragenyx. 1 therapy is approved with 1 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Phase 2
No programs
Approved1
Analysis
Trial Status
6
clinical trials
Completed3 · 50%
Active, not recruiting2 · 33%
Unknown status1 · 17%
Clinical Trials
Trial Activity
6 trials
Bilateral Temporomandibular Joint Assessment and Its Relationship With Clinical Parameters in Patients Who Develop Stroke Following a Cerebrovascular Event.
Active, not recruiting·—·N/A·NCT07698184·70 enrolled
The Effect of Good Limb Position Management Assistive Devices on Preventing Shoulder Subluxation in Hemiplegic Patients
Active, not recruiting·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·Preclinical·NCT07675759·80 enrolled
Investigation of the Effects of Upper Extremity Botulinum Toxin Application on Forearm Muscle Thickness and Motor Recovery in Patients With Hemiplegia
Completed·—·N/A·NCT07083752·20 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)